Stay updated on Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page shows an updated Revision: v3.6.4 tag. Older items such as Melanoma, related topics:, MedlinePlus Genetics, and Revision: v3.6.3 were removed, indicating a minor maintenance update to the page metadata.
    Difference
    0.1%
    Check dated 2026-07-22T09:26:23.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page gains additional related topics labels for Melanoma and MedlinePlus Genetics, enhancing navigational context and access to topic resources. These additions do not modify core study content, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-07-15T11:28:41.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The MedlinePlus related topics block—specifically Melanoma and MedlinePlus Genetics links—has been removed from the page, eliminating those quick-access resources.
    Difference
    0.1%
    Check dated 2026-07-08T08:06:26.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page now explicitly highlights Melanoma as a key topic and adds related topics and a MedlinePlus Genetics link, enhancing the study's contextual background; the revision tag was updated from v3.6.0 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-01T02:52:54.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Removal of the Melanoma term, the related topics header, and the MedlinePlus Genetics link from the study details page. These changes alter the page’s disease context and access to related educational resources.
    Difference
    0.1%
    Check dated 2026-06-23T23:43:24.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    The study page now states that recruitment is closed. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading along with a Revision: v3.6.0 tag.
    Difference
    0.3%
    Check dated 2026-06-16T19:59:18.000Z thumbnail image

Stay in the know with updates to Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.